Kiran Mazumdar

Shaw
Life
Born on 23rd
rd March, 1953 in Bangalore

Schooling at Bishop Cotton Girls School & Mount Carmel College

at Bangalore

B.Sc in Zoology from Bangalore University

Qualified as a master brewer from Ballarat Universtiy, Australia

CMD, Biocon Ltd., Indias biggest Biotechnology Company

In 2004, she became Indias Richect Woman

Personal Life
Kiran Mazumdar Shaw is married to John Shaw, a Scotsman and
Indophile.

John Shaw headed a leading textiles MNC, Madura Coats from

1991 to 1998 as CMD.

Currently, John Shaw is Vice-Chairman of Biocon, Ltd.

She has huge collections of paintings and other art works.

She has also written a coffee table book named Ale & Arty- the
story of Beer.
Mission or Vision??
Kiran Mazumdar Shaw personally did not believe in vision

She believed more in missions rather than vision.

Her mission was to build a biotech company that would be

respected globally.

And most importantly, she wanted to change perception that

India is not capable of a research-based business.

To her, a leader should have more missions than vision.

According to her, all leaders should be passionate about their

sense of purpose.
Quotes about Vision and
Mission..
All leaders need not be visionaries and all visionaries need not
be leaders.

There can be a leader without vision but there cant be a leader

without mission.

I believe that more than being a visionary, a leader must inspire

people, help them share their ideas and aspirations.

The vision concept is hyped and overstretched.

Journey of Bioconunder her
wings..
In 1978, she joined Biocon Biochemicals Limited, of Cork, Ireland
as a Trainee Manager.

In 1978 itself, she started Biocon in he garage in Bangalore with

a capital of Rs. 10,000.

Within a year, Biocon became the first Indian company to

manufacture and export enzymes to USA and Europe.

In 1990, she upgraded Biocons in-house research program,

based on a proprietary solid substrate fermentation technology.

The commercial success of this program led to a three-fold

expansion by 1996 and Biocon entered the biopharmaceuticals
and statins segments

In 1998, when Unilever agreed to sell its shareholding in Biocon

to the Indian promoters, Biocon became an independent entity.
In 2000, Biocon's proprietary bioreactor, christened PlafractorTM,
based on solid matrix fermentation received a U.S. patent.

By 2003 Biocon became the first company worldwide to develop

human insulin on a Pichia expression system.

In 2004, she decided to access the capital markets to develop

Biocons pipeline of research programs.

Biocons IPO was oversubscribed 32 times and its first day at the
bourses closed with a market value of $1.11 billion.

It made Biocon the 2nd nd only company to cross $1 billion mark on

the first day of listing.

She entered into more than 2,200 high-value R&D licensing and
other deals within the pharmaceuticals and bio-pharmaceutical
space between 2005 & 2010
Biocons Achievement
Med Ad News, in its
Med Ad News, in its
2007/08 listings has
2007/08 listings also
ranked Biocon 20th
ranked Biocon as 7th
amongst the leading
Largest Employer in the
biotechnology companies
world.
in the world.

Biocon also recently

received the 2009
BioSingapore Asia Pacific
Biotechnology Award for
Best Listed Company
Personal Achievement
198 NATIONAL INSTITUTE OF MARKETING MANAGEMENT, INDIA
2
1983 ROTARY CLUB, KARNATAKA

1989 PADMASHRI, GOI

1999 INTERNATIONAL WOMENS ASSOCIATION, CHENNAI

2002 ERNST & YOUNG

2005 HIGHEST CIVILIAN HONOURS

2009 EXPRESS PHARMACEUTICAL LEADERSHIP SUMMIT AWARD

2010 FORBES LIST

THANK
YOU